Dr. Daniela Kroshinsky, MD, MPH

Dr. Kroshinsky practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Kroshinsky's NPI, 1346372331, was assigned on March 12, 2007. Dr. Kroshinsky holds Massachusetts license 232377.

Dr. Kroshinsky's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Kroshinsky's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Kroshinsky is also affiliated with Duke University Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Kroshinsky to 1 more hospital, 3 medical groups, 2 group practices and clinics and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kroshinsky practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kroshinsky's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Kroshinsky's licenses on file in 2 states: Massachusetts and New York.

CMS data shows 232 Medicare services from Dr. Kroshinsky across 5 procedure codes in 2024, for 96 Medicare patients. Medicare paid $9,162 for them. Every service was in an office.

CMS counts 96 Medicare patients who saw Dr. Kroshinsky in 2024. The largest group is 65 to 74, with 54 patients. 67% of them have high blood pressure, and 61% have high cholesterol. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kroshinsky's median patient age at 40, with 59% women.

In 2024, Dr. Kroshinsky wrote 134 Medicare Part D claims for 55 patients. 92% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $362 in total drug cost. In 2023, CMS named 88 claims across 6 drugs.

Dr. Kroshinsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kroshinsky as offering telehealth. CMS counts 136 procedures of removal of skin lesions by Dr. Kroshinsky, more than 77% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 7 general payments to Dr. Kroshinsky from 4 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 65% of the total. Alnylam Pharmaceuticals Inc. paid the most, $3,510.